Canadian Cancer Trials Group

32.2k citations
409 papers ·

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

Canadian Cancer Trials Group

323 papers receiving 23.4k citations

Peers

Canadian Cancer Trials Group
Comparison fields: 5 of 184
  • Oncology 7.7k
  • Cancer Research 3.9k
  • Reproductive Medicine 2.0k
  • Pulmonary and Respiratory Medicine 5.7k
  • Otorhinolaryngology 616
Replace Eastern Cooperative Oncology Group with:
Eastern Cooperative Oncology Group United States
National Comprehensive Cancer Network United States
Smilow Cancer Hospital United States
Cancer Support Community United States
Herbert Irving Comprehensive Cancer Center United States
Radiation Oncology Institute United States
NSABP Foundation United States
MedStar Franklin Square Medical Center United States
Boston Collaborative Drug Surveillance Program United States
Harvard Vanguard Medical Associates United States
Canadian Cancer Trials Group relative to Eastern Cooperative Oncology Group United States Eastern Cooperative Oncology Group's profile →
Citations per field
00.5×1.5×1.9×
Eastern Cooperative Oncology Group · 1×
Citations per year

Countries citing scholars working at Canadian Cancer Trials Group

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Canadian Cancer Trials Group. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Canadian Cancer Trials Group with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canadian Cancer Trials Group more than expected).

Fields of papers published by authors at Canadian Cancer Trials Group

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Canadian Cancer Trials Group at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Canadian Cancer Trials Group at the time of their publication.

About Canadian Cancer Trials Group

In recent decades, authors affiliated with Canadian Cancer Trials Group have published 409 papers, which have received a total of 32.2k indexed citations . Scholars at this organization have produced 123 papers in Oncology, 35 papers in Statistics and Probability, 56 papers in Cancer Research, 30 papers in Reproductive Medicine and 87 papers in Pulmonary and Respiratory Medicine on the topics of Statistical Methods in Clinical Trials (32 papers), Ovarian cancer diagnosis and treatment (30 papers), Lymphoma Diagnosis and Treatment (30 papers), Lung Cancer Treatments and Mutations (30 papers), Cancer Genomics and Diagnostics (28 papers), Cancer Treatment and Pharmacology (22 papers), Breast Cancer Treatment Studies (22 papers) and HER2/EGFR in Cancer Research (18 papers). Their work is cited by papers focused on Oncology (7.7k citations), Cancer Research (3.9k citations), Reproductive Medicine (2.0k citations), Pulmonary and Respiratory Medicine (5.7k citations) and Otorhinolaryngology (616 citations). Authors at Canadian Cancer Trials Group collaborate with scholars in Canada, United States and United Kingdom and have published in prestigious journals including Annals of Oncology, Journal of Clinical Oncology, Blood, Investigational New Drugs and European Journal of Cancer. Some of Canadian Cancer Trials Group's most productive authors include Wendy R. Parulekar, Kay Dickersin, Kenneth F. Schulz, Peter Christian Gøtzsche, Jesse A. Berlin, Jennifer Tetzlaff, Douglas G. Altman, David Moher, Karmela Krleža-Jerić and Elizabeth A. Eisenhauer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact